PUBLISHED DATE : Aug 2020 | Pages : 292
Fill out your details & get your free sample
Syringe and Needles Market Size, Share, & Trends Analysis Report By Products (Syringes and Needles), Patient Group (Adults and Pediatric Patients), End-users (Hospitals, Clinics, Home Healthcare Settings, and Others), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025
292 Pages
70 Tables
155 Charts
5 Regions
19 Countries
41 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (Revenue) | USD 34 Billion (2025) |
| CAGR | 10% (2020-2025) |
| BASE YEAR | 2019 |
| FORECAST PERIOD | 2020-2025 |
| MARKET SEGMENTATION | Products (Syringes and Needles), Patient Group (Adults and Pediatric Patients ), and End-users (Hospitals, Clinics, Home Healthcare Settings, and Others) |
| GEOGRAPHICAL ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| COUNTRIES COVERED | US, Canada, UK, Germany, Russia, France, Italy, Spain, Japan, China, India, South Korea, Australia Brazil, Mexico, Argentine, South Africa, Saudi Arabia, and Turkey |
The global syringe and needles market size to cross USD 34 billion by 2025, growing at a CAGR of 10% during the forecast period. The global market constitutes an essential segment of the global medical devices market. The market is majorly driven by the rising incidence of trauma cases (accidents and burn cases), the growing prevalence of chronic diseases, and the increasing incidence of hospital-acquired infections. Chronic diseases such as diabetes require medical products such as needles and syringes for the administration of insulin and drawing blood samples for monitoring glucose levels. Hence, the market is likely to grow due to the increasing prevalence of diabetics across the globe. With increasing instances of hospital-acquired infections, there is a high demand to reduce hospital-acquired infections and maintain safe laboratory practices. Hence, the increased focus to avoid needle stick injuries and infection transmissions by medical practitioners is boosting the growth of safety syringes and needles in the market.
This research report includes a detailed segmentation by
North America dominates the syringe market. The Asia Pacific region is expected to grow at a faster growth rate due to the presence of a large patient population that requires syringes for medication and blood testing. The increased adoption of injectable drugs, technological advancements, the increase in the geriatric population, and the growing number of vaccination and immunization programs for pediatrics, as well as adults, are expected to drive the volume growth over the next few years. The syringe market is categorized based on type and usability. By type, the segment is further divided into general and specialized syringes. The general segment dominated the market in 2019, while the specialized segment is expected to grow at a faster growth rate during the forecast period. In terms of usability, the syringes segment is segmented into disposable and sterilizable. The disposable syringes market dominated the market share of 90%. The sterilizable segment accounted for a 10% market share.
The needles market is growing, with an incremental growth of $4.78 billion. This growth is due to the increasing demand for needles to administrate drugs and supply nutrients to patients. The increasing prevalence of diabetes is boosting the demand for injecting insulin. Also, the increasing patient population due to the pandemic cases of COVID-19 is increasing the demand for needles and syringes during the forecast period. With the introduction and enforcement of stringent legislation and guidelines, there is a rise in the adoption of safety needles among hospitals and individuals. The demand for safety hypodermic needles is expected to increase with the rising popularity of safety syringes and needles and other safety-engineered medical devices.
The adult segment accounted for a 65% share of the global market in 2019. The segment is the major revenue contributor on account of the increasing application of injections to treat diseases such as cancer, diabetes, and several viral infections. The growing elderly population, which is prone to chronic diseases, is another major revenue contributor to the healthcare industry as this patient group requires medical supervision. The rise in hospital admissions is due to the increase in cancer, cardiovascular ailments, and other infectious and chronic disease prevalence has driven syringes and needles demand.
The pediatric segment is expected to grow at the fastest CAGR during the forecast period. The segment is driven by improving birth rates across the world, boosting the usage of injections. Moreover, the increase in chronic disease prevalence in the pediatric population is one of the significant factors that is driving the usage of syringes and needles. It has been estimated that chronic health conditions affect 10% to 30% of children across the world.
The hospital end-user segment is dominating the market and accounted for 55% of the global syringe and needle market share in 2019. Hospitals are the major revenue contributors. All hospitals use needles and syringes to withdraw blood or fluid samples and administer drugs or vaccinations. In emergency and inpatient settings, the injections are used on a large scale for medication and collection of multiple blood specimens for diagnosis and treatment purposes for the patients in critical care.
The market is witnessing the growing adoption of advanced syringes to minimize the risk of vessel intima. Advanced and safety needles and syringes are reducing the risk of needle stick injuries and transmission of infectious diseases among patients and healthcare providers. The outbreak of the COVID-19 pandemic is increasing hospital admissions, thereby increasing the demand for injections.
The clinic end-user segment is expected to grow at a CAGR of over 9% during the period 2019¬2025. IVF and rehabilitation clinics use a high number of needles and syringes for medical and vaccination procedures, thereby boosting the market. Similarly, the home care setting segment is expected to experience growth as the elderly population prefers these settings over hospitals and other clinics.
The North American region is driven by the rising incidence of chronic and infectious diseases, with hospitals, clinics, and ASCs emerging as the major revenue generators. The US and Canada are the primary revenue contributors to the market. The adoption of syringes and needles with safety mechanisms is higher in North America than in other geographical regions. End-users prefer the use of safety-engineered products, which, in turn, has increased the demand for such products. Moreover, the practice of safe community disposal has helped reduce medical contamination from needles, syringes, and cannula. The market is growing at a significant pace, which is expected to continue during the forecast period due to the rise in demand for safety injections and advanced cannula to reduce the incidences of needle stick injuries.
The global syringes and needles market share is fragmented and is currently intensifying due to the rapidly changing technological environment. Becton, Dickinson and Company, B Braun Melsungen, Nipro Corporation, Terumo, and Teleflex are the key players. All these companies have a significant presence in major geographical regions such as North America, APAC, and Europe. However, there are many local vendors providing products with similar specifications at low prices, which results in a price war among vendors. The major vendors are competing among themselves for the leading position in the market, with occasional spurts of competition coming from other local vendors.
Segmentation by Products
Needles
By Patient Group
By End-users
By Geography
Frequently Asked Questions
What is the global syringe and needle market size and growth forecast?
Syringe and needle market size is expected reach revenues of over $34 billion by 2025, growing at a CAGR of 10% during the forecast period
Which is the leading region/segment dominating the syringe and needle market?
The North American region is leading and driven by the rising incidence of chronic and infectious diseases, with hospitals, clinics, and ASCs emerging as the major revenue generators. The hospital end-user segment is dominating the market and accounted for a 55% market share.
How is COVID-19 impacting the market growth during the forecast period?
The increasing patient population and hospital admissions due to the pandemic cases of COVID-19 is increasing the demand for needles and syringes during the forecast period.
Who are the strategic leaders in the syringe and needle market, and what are their shares?
Becton, Dickinson and Company, B Braun Melsungen, Nipro Corporation, Terumo, and Teleflex are the key players.
What are some of the major factors influencing the syringe industry?
The market is majorly driven by the rising incidence of trauma cases (accidents and burn cases), the growing prevalence of chronic diseases, and the increasing incidence of hospital-acquired infections.
The syringe and needle market is expected to grow at a CAGR of over 10% during the period 2019–2025.
The following factors are likely to contribute to the growth of the market during the forecast period:
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the syringe and needle market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
Other Prominent Vendors
Segmentation by Products
Segmentation by Patient Group
Segmentation by End-users
Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusion
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Growing Demand for Self-Injection Devices & Prefilled Syringes
8.2 Rapid Advancements in Needle & Syringe Design & Technology
8.3 High Growth Potential in Emerging Economies
9 Market Growth Enablers
9.1 Increasing Target Population
9.2 Growing Demand for Safety Needles & Syringes
9.3 Favorable Government Initiatives & Rising Awareness about Safe Injection Practices
9.4 Global Expansion of Needle Syringe Programs
9.5 High Demand for Biologics Using Parenteral Drug Delivery
10 Market Restraints
10.1 Risks Associated With Needles & Syringes
10.2 Growing Focus on Development of Alternative Drug Delivery Methods
10.3 Stringent Regulations & Legislation for Syringes & Needles
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Syringe and Needle Market By Syringes
12.1 Market Overview
12.2 By Product Type
12.2.1 Snapshot & Growth Engine
12.2.2 Overview
12.2.3 General Syringes: Size & Forecast
12.2.4 Specialized Syringes: Size & Forecast
12.3 By Usability
12.3.1 Snapshot & Growth Engine
12.3.2 Overview
12.3.3 Disposable Syringes: Size & Forecast
12.3.4 Sterilizable Syringes Size & Forecast
13 Market By Needles
13.1 Snapshot & Growth Engine
13.2 Overview
13.3 By Type
13.3.1 Overview
13.3.2 Conventional Needles Size & Forecast
13.3.3 Safety Needles Size & Forecast
14 Syringe and Needle Market By Patient Group
14.1 Snapshot & Growth Engine
14.2 Overview
14.3 Adults
14.3.1 Overview
14.3.2 Size & Forecast
14.4 Pediatrics
14.4.1 Overview
14.4.2 Size & Forecast
15 Syringe and Needle Market End-Users
15.1 Snapshot & Growth Engine
15.2 Overview
15.3 Hospitals
15.3.1 Overview
15.3.2 Size & Forecast
15.4 Clinics
15.4.1 Overview
15.4.2 Size & Forecast
15.5 Home Healthcare Settings
15.5.1 Overview
15.5.2 Size & Forecast
15.6 Others
15.6.1 Overview
15.6.2 Size & Forecast
16 Market By Geography
16.1 Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Overview
17.2 Size & Forecast
17.3 North America: Product Segmentation
17.3.1 Size & Forecast
17.4 Key Countries
17.5 US:Market Size & Forecast
17.6 Canada: Size & Forecast
18 Europe
18.1 Overview
18.2 Size & Forecast
18.3 Europe: Product Segmentation
18.4 Key Countries
18.5 Germany:Market Size & Forecast
18.6 UK: Size & Forecast
18.7 France: Syringe and Needle Market Size & Forecast
18.8 Italy: Size & Forecast
18.9 Spain:Market Size & Forecast
18.10 Russia: Size & Forecast
19 APAC
19.1 Overview
19.2 Size & Forecast
19.3 APAC: Product Segmentation
19.3.1 Size & Forecast
19.4 Key Countries
19.5 China: Market Size & Forecast
19.6 Japan: Size & Forecast
19.7 India:Market Size & Forecast
19.8 South Korea: Size & Forecast
19.9 Australia: Syringe and Needle Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Size & Forecast
20.3 Latin America: Product Segmentation
20.3.1 Size & Forecast
20.4 Key Countries
20.5 Brazil:Market Size & Forecast
20.6 Mexico: Size & Forecast
20.7 Argentina: Syringe and Needle Market Size & Forecast
21 Middle East & Africa
21.1 Market Overview
21.2 Size & Forecast
21.3 Middle East & Africa: Product Segmentation
21.3.1 Size & Forecast
21.4 Key Countries
21.5 Turkey:Market Size & Forecast
21.5.1 South Africa: Size & Forecast
21.5.2 Saudi Arabia: Syringe and Needle Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 BD
22.2.2 B. Braun Melsungen
22.2.3 Terumo
22.2.4 Teleflex
22.2.5 Nipro
22.2.6 Smiths Medical
22.2.7 Cardinal Health
23 Key Company Profiles
23.1 BD
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 B. Braun Melsungen
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Terumo
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 Teleflex
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Nipro
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Smiths Medical
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
23.7 Cardinal Health
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
24 Other Prominent Vendors
24.1 Allison Medical
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 Apexmed International
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Argon Medical Devices
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Artsana
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 Codan Medizinische Geräte
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Connecticut Hypodermics
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Exelint International
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 GERRESHEIMER
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 Hindustan Syringes & Medical Devices
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 International Medsurg Connection
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Retractable Technologies
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Ultimed
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Unimed
24.13.1 Business overview
24.13.2 Product Offerings
24.14 West Pharmaceutical Services
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Vita Needle Company
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 Aspen Surgical
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 BESPAK
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 Credence Medsystems
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 DALI MEDICAL DEVICES
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Deroyal
24.20.1 Business Overview
24.20.2 Product Offerings
24.21 GBUK
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 Medtronic
24.22.1 Business Overview
24.22.2 Product Offerings
24.23 MHC Medical Products
24.23.1 Business Overview
24.23.2 Product Offerings
24.24 Micsafe Medical Group
24.24.1 Business Overview
24.24.2 Product Offerings
24.25 MORIA
24.25.1 Business Overview
24.25.2 Product Offerings
24.26 Nemera
24.26.1 Business Overview
24.26.2 Product Offerings
24.27 NOVO Nordisk
24.27.1 Business Overview
24.27.2 Product Offerings
24.28 RAYS
24.28.1 Business Overview
24.28.2 Product Offerings
24.29 SCHOTT
24.29.1 Business Overview
24.29.2 Product Offerings
24.30 Troge Medical
24.30.1 Business Overview
24.30.2 Product Offerings
24.31 VAN Oostveen Medical
24.31.1 Business Overview
24.31.2 Product Offerings
24.32 Vygon
24.32.1 Business Overview
24.32.2 Product Offerings
24.33 Wujiang Evergreen EX/IM
24.33.1 Business Overview
24.33.2 Product Offerings
24.34 YPSOMED
24.34.1 Business overview
24.34.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 By Product
26.2 By Patient Group
26.3 By Geography
26.4 By End-Users
26.5 By Syringe Type
26.6 By Syringe Usability
26.7 By Needle Type
27 Appendix
27.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Syringe and Needle Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Prevalence of NSIs
Exhibit 4 Impact of Growing Demand for Self-Injection Devices & Pre-filled Syringes
Exhibit 5 Global Diabetes Prevalence 2014 & 1980 (million)
Exhibit 6 Impact of Rapid Advancements in Needle & Syringe Design & Technology
Exhibit 7 Impact of High Growth Potential in Emerging Economies
Exhibit 8 Prevalence of Chronic Diseases in Developed & Developing Countries 2019
Exhibit 9 Impact of Increasing Target Patient Population
Exhibit 10 Number of People Living with HIV & Accessing Treatment Globally 2000−2018
Exhibit 11 Share of Chronic Conditions in Various Countries
Exhibit 12 Global Cancer Incidence by Region 2018 (%)
Exhibit 13 Estimated Prevalence of Injecting Drug Use (IDU) by Country
Exhibit 14 Impact of Growing Demand for Safety Needles & Syringes
Exhibit 15 Relative Frequency of Needle-Stick Injury (%)
Exhibit 16 NSI Cases by Profession
Exhibit 17 Impact of Favourable Government Initiatives & Rising Awareness about Safe Injection Practices
Exhibit 18 Key Areas Covered by WHO’s SIGN Safe Injection Practice Toolkit
Exhibit 19 OSHA Best Management Practice for Sharp Handling & Disposable
Exhibit 20 Impact of Global Expansion of Needle Syringe Programs
Exhibit 21 NSPs
Exhibit 22 Community Benefits of NSPs
Exhibit 23 Impact of High Demand for Biologics using Parenteral Drug Delivery
Exhibit 24 Impact of Risks Associated with Needles & Syringes
Exhibit 25 Percentage of Event/Occurrence of NSIs
Exhibit 26 Prevalence of NSIs by Profession
Exhibit 27 Prevalence of HCAI in Developed & Developing countries
Exhibit 28 Impact of Growing Focus on Development of Alternative Drug Delivery Methods
Exhibit 29 Types of Needle Free Injections
Exhibit 30 Number of End-users Willing to Adopt NFT (%)
Exhibit 31 Advantages of NFT
Exhibit 32 Impact of Stringent Regulations & Legislations for Syringes & Needles
Exhibit 33 The One and Only Campaign
Exhibit 34 Steps to be Taken by Healthcare Physicians & Workers
Exhibit 35 Global Syringe and Needle Market 2019–2025 ($ billion)
Exhibit 36 Global Syringe and Needle Market by Product
Exhibit 37 Global Syringe and Needle Market by Patient Group
Exhibit 38 Global Syringe and Needle Market By End-user
Exhibit 39 Five Forces Analysis 2019
Exhibit 40 Global Syringes Market
Exhibit 41 Global Syringes Market: Incremental Growth & Absolute Growth
Exhibit 42 Incremental Growth by Product Type 2019 & 2025
Exhibit 43 Global Syringes Market by Type 2019 ($ billion)
Exhibit 44 Global Market by Type 2019 & 2025 (%)
Exhibit 45 Global General Syringes Market: Increment & Absolute Growth Comparison
Exhibit 46 Global Market 2019 & 2025 ($ billion)
Exhibit 47 Global Market 2019–2025 ($ billion)
Exhibit 48 Global Specialized Syringes Market Share 2019 & 2025 (%)
Exhibit 49 Global Market: Increment & Absolute Growth Comparison
Exhibit 50 Global Market 2019–2025 ($ billion)
Exhibit 51 Incremental Growth by Usability 2019 & 2025
Exhibit 52 Global Syringes Market by Usability 2019 & 2025 ($ billion)
Exhibit 53 Market Share by Usability (%) 2019 & 2025
Exhibit 54 Disposable Syringes Market Share 2019 & 2025 (%)
Exhibit 55 Types of Disposable Syringes
Exhibit 56 Disposable Syringes Market: Incremental & Absolute Growth
Exhibit 57 Global Market 2019–2025 ($ billion)
Exhibit 58 Global Sterilizable Syringes Market 2019 & 2028 ($ billion)
Exhibit 59 Prevalence of NSIs by Healthcare Professionals (%)
Exhibit 60 Global Market 2019–2025 ($ billion)
Exhibit 61 Incremental Growth by Needles 2019 & 2025 ($ billion)
Exhibit 62 Global Needles Market
Exhibit 63 Global Needles Market: Incremental & Absolute Growth
Exhibit 64 Benefits of Different Gauge Needles
Exhibit 65 Global Market Share 2019 & 2025 (%)
Exhibit 66 Market by Type Revenue 2019 ($ billion)
Exhibit 67 Market Share by Type 2019 & 2025 (%)
Exhibit 68 Conventional Needles Market Share 2019 & 2025 (%)
Exhibit 69 Prevalence of Chronic Disease in Developed & Developing Countries 2019
Exhibit 70 Global Market: Incremental & Absolute Growth
Exhibit 71 Global Market 2019–2025 ($ billion)
Exhibit 72 Safety Needles Market Share 2019 & 2025 (%)
Exhibit 73 Global Market: Incremental & Absolute Growth
Exhibit 74 Global Market 2019–2025 ($ billion)
Exhibit 75 Incremental Growth by Patient Group 2019 & 2025
Exhibit 76 Global Patient Group Market
Exhibit 77 Global Syringe and Needle Market by Patient Group: Incremental Growth ($ billion)
Exhibit 78 Global Market by Patient Group: Absolute Growth (%)
Exhibit 79 Population Over 65 Years in 2019 (% population)
Exhibit 80 Global Adult Market 2019–2025 ($ billion)
Exhibit 81 Number of Childbirths in 2018
Exhibit 82 WHO Chart for Vaccination
Exhibit 83 Global Pediatric Needles & Syringes Market 2019–2025 ($ billion)
Exhibit 84 Incremental Growth by End-Users 2019 & 2025
Exhibit 85 Global Needles & Syringes End-user Market
Exhibit 86 Global Syringe and Needle Market by End-user: Incremental Growth ($ billion)
Exhibit 87 Global Market by End-user: Absolute Growth (%)
Exhibit 88 Global Hospitals Market 2019–2025 ($ billion)
Exhibit 89 Global Clinics Market 2019–2025 ($ billion)
Exhibit 90 Services Included in Home Healthcare Settings
Exhibit 91 Global Home Healthcare Settings Market 2019–2025 ($ billion)
Exhibit 92 Global Other End-users Market 2019–2025 ($ billion)
Exhibit 93 Incremental Growth by Geography 2019 & 2025
Exhibit 94 Global Syringe and Needle Market by Geography
Exhibit 95 Global Market by Geography: Incremental Growth ($ billion)
Exhibit 96 Global Market by Geography: Absolute Growth ($ billion)
Exhibit 97 Market in North America in 2019
Exhibit 98 COVID-19 Prevalence Data in North America
Exhibit 99 Prevalence of HIV Among People Who Inject Drugs
Exhibit 100 Market in North America 2019–2025 ($ billion)
Exhibit 101 Incremental Growth in North America 2019 & 2025
Exhibit 102 Diabetes Prevalence Among Individuals Aged 18 Years & Above in US 2018 (billion)
Exhibit 103 Market in US 2019–2025 ($ billion)
Exhibit 104 Market in Canada 2019–2025 ($ billion)
Exhibit 105 Market in Europe in 2019
Exhibit 106 NSI Prevalence in Europe
Exhibit 107 Market in Europe 2019–2025 ($ billion)
Exhibit 108 Incremental Growth in Europe 2019 & 2025
Exhibit 109 Market in Germany 2019–2025 ($ billion)
Exhibit 110 Market in UK 2019–2025 ($ billion)
Exhibit 111 Market in France 2019–2025 ($ billion)
Exhibit 112 Market in Italy 2019–2025 ($ billion)
Exhibit 113 Population Aged 65 & Above (% of total population) – Spain 2014, 2016 & 2018
Exhibit 114 Market in Spain 2019–2025 ($ billion)
Exhibit 115 Population Aged 65 & Above (% of total population) - Russian Federation 2016−2018
Exhibit 116 Market in Russia 2019–2025 ($ billion)
Exhibit 117 APAC Syringe and Needle Market 2019
Exhibit 118 Market in APAC 2019–2025 ($ billion)
Exhibit 119 Incremental Growth in APAC 2019 & 2025
Exhibit 120 Market in China 2019–2025 ($ billion)
Exhibit 121 Market in Japan 2019–2025 ($ billion)
Exhibit 122 Population Ages 65 and Above (% of the total population) – India from 2016−2018
Exhibit 123 Market in India 2019–2025 ($ billion)
Exhibit 124 Market in South Korea 2019–2025 ($ billion)
Exhibit 125 Market in Australia 2019–2025 ($ billion)
Exhibit 126 Latin America Syringe and Needle Market 2019
Exhibit 127 Market in Latin America 2019–2025 ($ billion)
Exhibit 128 Incremental Growth in Latin America 2019 & 2025
Exhibit 129 Market in Brazil 2019–2025 ($ billion)
Exhibit 130 Market in Mexico 2019–2025 ($ billion)
Exhibit 131 Market in Argentina 2019–2025 ($ billion)
Exhibit 132 Market in MEA in 2019
Exhibit 133 Vaccine Procurement Modalities in MENA 2017
Exhibit 134 Market in MEA 2019–2025 ($ billion)
Exhibit 135 Incremental Growth in MEA 2019 & 2025
Exhibit 136 Market in Turkey 2019–2025 ($ billion)
Exhibit 137 Market in South Africa 2019–2025 ($ billion)
Exhibit 138 Market in Saudi Arabia 2019–2025 ($ billion)
Exhibit 139 BD’s Revenue 2017−2019 ($ million)
Exhibit 140 BD’s Revenue by Geography 2017−2019 ($ million)
Exhibit 141 BD Revenue 2017–2019 ($ million)
Exhibit 142 BD Revenue by Business Segments ($ billion)
Exhibit 143 B. Braun Melsungen Revenue by Division FY2018 and FY2019 ($ million)
Exhibit 144 B. Braun Melsungen R&D Expenditure in FY17, FY18, and FY19 ($ million)
Exhibit 145 B. Braun Melsungen Sales by Region FY19 (%)
Exhibit 146 Terumo Revenue 2018 & 2019 ($ million)
Exhibit 147 Teleflex Revenue 2016−2018 ($ million)
Exhibit 148 Teleflex R&D Expenditure 2016−2018 ($ million)
Exhibit 149 Nipro Revenue 2019 & 2018 ($ million)
Exhibit 150 Nipro Revenue by Business Segment 2019 ($ million)
Exhibit 151 Smiths Medical: 2018 & 2019 Revenue ($ million)
Exhibit 152 Smiths Medical: R&D Expenditure 2018 & 2019 ($ million)
Exhibit 153 Smiths Revenue Share by Business Segments 2019 (%)
Exhibit 154 Cardinal Health Revenue 2019 & 2018 ($ billion)
Exhibit 155 Cardinal Health Revenue by Business Segment 2019 ($ billion)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 Type of Medical-Surgical Device
Table 4 Comparison of HAIs in Developed and Developing Countries
Table 5 Syringe and Needle Market in North America by Product 2019−2025 ($ billion)
Table 6 Market in North America by Product 2019−2025 (%)
Table 7 Market in Europe by Product 2019−2025 ($ billion)
Table 8 Market in Europe by Product 2019−2025 (%)
Table 9 Market in APAC by Product 2019−2025 ($ billion)
Table 10 Market in APAC by Product 2019−2025 (%)
Table 11 Market in Latin America by Product 2019−2025 ($ billion)
Table 12 Market in Latin America by Product 2019−2025 (%)
Table 13 Market in MEA by Product 2019−2025 ($ billion)
Table 14 Market in MEA by Product 2019−2025 (%)
Table 15 Global Syringe and Needle Market: Vendors Ranking 2019
Table 16 BD: Major Product Offerings
Table 17 B. Braun Melsungen: Major Product Offerings
Table 18 Terumo: Major Product Offerings
Table 19 Teleflex: Major Product Offerings
Table 20 Nipro: Major Product Offerings
Table 21 Smiths Medical: Major Product Offerings
Table 22 Cardinal Health: Major Product Offerings
Table 23 Allison Medical: Major Product Offerings
Table 24 APEXMED International: Major Product Offerings
Table 25 Argon Medical Devices: Major Product Offerings
Table 26 Artsana: Major Product Offerings
Table 27 CODAN Medizinische Geräte: Major Product Offerings
Table 28 Connecticut Hypodermics: Major Product Offerings
Table 29 EXELINT International: Major Product Offerings
Table 30 Gerresheimer: Major Product Offerings
Table 31 Hindustan Syringes & Medical Devices: Major Product Offerings
Table 32 International Medsurg Connection: Major Product Offerings
Table 33 Retractable Technologies: Major Product Offerings
Table 34 UltiMed: Major Product Offerings
Table 35 Unimed: Major Product Offerings
Table 36 West Pharmaceutical Services: Major Product Offerings
Table 37 Vita Needle Company: Major Product Offerings
Table 38 Aspen Surgical: Major Product Offerings
Table 39 Bespak: Major Product Offerings
Table 40 Credence MedSystems: Major Product Offerings
Table 41 Dali Medical Devices: Major Product Offerings
Table 42 DeRoyal: Major Product Offerings
Table 43 GBUK: Major Product Offerings
Table 44 Medtronic: Major Product Offerings
Table 45 MHC Medical Products: Major Product Offerings
Table 46 Micsafe Medical Group: Major Product Offerings
Table 47 Moria: Major Product Offerings
Table 48 Nemera: Major Product Offerings
Table 49 Novo Nordisk: Major Product Offerings
Table 50 Rays: Major Product Offerings
Table 51 Schott: Major Product Offerings
Table 52 Troge Medical: Major Product Offerings
Table 53 Van Oostveen Medical: Major Product Offerings
Table 54 Vygon: Major Product Offerings
Table 55 Wujiang Evergreen EX/IM: Major Product Offerings
Table 56 Ypsomed: Major Product Offerings
Table 57 Global Syringe and Needle Market by Product 2019−2025 ($ billion)
Table 58 Global Market by Product 2019−2025 (%)
Table 59 Global Market by Patient Group 2019−2025 ($ billion)
Table 60 Global Market by Patient Group 2019−2025 (%)
Table 61 Global Market by Geography 2019−2025 ($ billion)
Table 62 Global Market by Geography 2019−2025 (%)
Table 63 Global Market by End-users 2019−2025 ($ billion)
Table 64 Global Market by End-users 2019−2025 (%)
Table 65 Global Syringes Market by Type 2019−2025 ($ billion)
Table 66 Global Market by Type 2019−2025 (%)
Table 67 Global Syringes Market by Usability 2019−2025 ($ billion)
Table 68 Global Market by Usability 2019−2025 (%)
Table 69 Global Needles Market by Type 2019−2025 ($ billion)
Table 70 Global Market by Needle Type 2019−2025 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
